GENEVA, April 9 (Reuters) - China&aposs COVID-19 vaccines, made by Sinopharm and Sinovac SVA.O , are in final stages of review for emergency use listing by the World Health Organization (WHO) which expects to decide on at least one at an April 26 meeting, its regulation director Rogerio Gaspar said on Friday.

A second meeting was planned for the week of May 3, which would allow for reviewing the second one as needed, he said.

WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility and is also a signal to countries with weaker regulatory agencies about a vaccine&aposs safety and efficacy.